Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 3 |
2017 | 1 |
2018 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Clin Cancer Res. 2021 Apr 15;27(8):2179-2189. doi: 10.1158/1078-0432.CCR-20-3909. Epub 2021 Jan 27.
Clin Cancer Res. 2021.
PMID: 33504555
Free PMC article.
Clinical Trial.
Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
Williams RT, Barnhill LM, Kuo HH, Lin WD, Batova A, Yu AL, Diccianni MB.
Williams RT, et al.
PLoS One. 2014 Feb 5;9(2):e88219. doi: 10.1371/journal.pone.0088219. eCollection 2014.
PLoS One. 2014.
PMID: 24505435
Free PMC article.
Item in Clipboard
High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma.
Barnhill LM, Williams RT, Cohen O, Kim Y, Batova A, Mielke JA, Messer K, Pu M, Bao L, Yu AL, Diccianni MB.
Barnhill LM, et al.
Cancer Res. 2014 Jul 15;74(14):3753-63. doi: 10.1158/0008-5472.CAN-13-3447.
Cancer Res. 2014.
PMID: 25028366
Free PMC article.
Item in Clipboard
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.
Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL.
Ozkaynak MF, et al.
Front Immunol. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355. eCollection 2018.
Front Immunol. 2018.
PMID: 29967609
Free PMC article.
Item in Clipboard
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.
Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Gilman AL, Yu AL, Sondel PM.
Erbe AK, et al.
Clin Cancer Res. 2018 Jan 1;24(1):189-196. doi: 10.1158/1078-0432.CCR-17-1767. Epub 2017 Oct 2.
Clin Cancer Res. 2018.
PMID: 28972044
Free PMC article.
Item in Clipboard
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia.
Terme M, Dorvillius M, Cochonneau D, Chaumette T, Xiao W, Diccianni MB, Barbet J, Yu AL, Paris F, Sorkin LS, Birklé S.
Terme M, et al.
PLoS One. 2014 Feb 10;9(2):e87210. doi: 10.1371/journal.pone.0087210. eCollection 2014.
PLoS One. 2014.
PMID: 24520328
Free PMC article.
Item in Clipboard
Cite
Cite